Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 326


Stress Cardiac MRI in Women With Myocardial Infarction and Nonobstructive Coronary Artery Disease.

Mauricio R, Srichai MB, Axel L, Hochman JS, Reynolds HR.

Clin Cardiol. 2016 Oct;39(10):596-602. doi: 10.1002/clc.22571.


Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial.

Kaul P, Ohman EM, Knight JD, Anstrom KJ, Roe MT, Boden WE, Hochman JS, Gašparović V, Armstrong PW, McCollam P, Fakhouri W, Cowper P, Davidson-Ray L, Clapp-Channing N, White HD, Fox KA, Prabhakaran D, Mark DB; TRILOGY ACS Investigators..

Am Heart J. 2016 Aug;178:55-64. doi: 10.1016/j.ahj.2016.03.017.


Rates of Invasive Management of Cardiogenic Shock in New York Before and After Exclusion From Public Reporting.

Bangalore S, Guo Y, Xu J, Blecker S, Gupta N, Feit F, Hochman JS.

JAMA Cardiol. 2016 Sep 1;1(6):640-7. doi: 10.1001/jamacardio.2016.0785.


Perspectives from NHLBI Global Health Think Tank Meeting for Late Stage (T4) Translation Research.

Engelgau MM, Peprah E, Sampson UK, Mishoe H, Benjamin IJ, Douglas PS, Hochman JS, Ridker PM, Brandes N, Checkley W, El-Saharty S, Ezzati M, Hennis A, Jiang L, Krumholz HM, Lamourelle G, Makani J, Narayan KM, Ohene-Frempong K, Straus SE, Stuckler D, Chambers DA, Belis D, Bennett GC, Boyington JE, Creazzo TL, de Jesus JM, Krishnamurti C, Lowden MR, Punturieri A, Shero ST, Young NS, Zou S, Mensah GA.

Glob Heart. 2016 Jul 21. pii: S2211-8160(16)30640-8. doi: 10.1016/j.gheart.2016.03.640. [Epub ahead of print]


Management of refractory cardiogenic shock.

Reyentovich A, Barghash MH, Hochman JS.

Nat Rev Cardiol. 2016 Aug;13(8):481-92. doi: 10.1038/nrcardio.2016.96. Review.


Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.

Wallentin L, Held C, Armstrong PW, Cannon CP, Davies RY, Granger CB, Hagström E, Harrington RA, Hochman JS, Koenig W, Krug-Gourley S, Mohler ER 3rd, Siegbahn A, Tarka E, Steg PG, Stewart RA, Weiss R, Östlund O, White HD; STABILITY Investigators..

J Am Heart Assoc. 2016 Jun 21;5(6). pii: e003407. doi: 10.1161/JAHA.116.003407.


Treatment of Patients With Stable Ischemic Heart Disease--Reply.

Bangalore S, Maron DJ, Hochman JS.

JAMA. 2016 May 3;315(17):1905-6. doi: 10.1001/jama.2016.0698. No abstract available.


Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.

Vavalle JP, van Diepen S, Clare RM, Hochman JS, Weaver WD, Mehta RH, Pieper KS, Patel MR, Patel UD, Armstrong PW, Granger CB, Lopes RD.

Am Heart J. 2016 Mar;173:57-66. doi: 10.1016/j.ahj.2015.12.001.


Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.

Stone GW, Hochman JS, Williams DO, Boden WE, Ferguson TB Jr, Harrington RA, Maron DJ.

J Am Coll Cardiol. 2016 Jan 5;67(1):81-99. doi: 10.1016/j.jacc.2015.09.056. Review.


Frequency, clinical and angiographic characteristics, and outcomes of high-risk non-ST-segment elevation acute coronary syndromes patients with left circumflex culprit lesions.

Halim SA, Clare RM, Newby LK, Lokhnygina Y, Schweiger MJ, Hof AW, Hochman JS, James SK, White HD, Widimsky P, Betriu A, Bode C, Giugliano RP, Harrington RA, Zeymer U.

Int J Cardiol. 2016 Jan 15;203:708-13. doi: 10.1016/j.ijcard.2015.11.036.


Evidence-Based Management of Stable Ischemic Heart Disease: Challenges and Confusion.

Bangalore S, Maron DJ, Hochman JS.

JAMA. 2015 Nov 10;314(18):1917-8. doi: 10.1001/jama.2015.11219. No abstract available.


Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.

Clemmensen P, Roe MT, Hochman JS, Cyr DD, Neely ML, McGuire DK, Cornel JH, Huber K, Zamoryakhin D, White HD, Armstrong PW, Fox KA, Prabhakaran D, Ohman EM; TRILOGY ACS Investigators..

Am Heart J. 2015 Oct;170(4):695-705.e5. doi: 10.1016/j.ahj.2015.06.011.


Teaching Translational Research to Medical Students: The New York University School of Medicine's Master's of Science in Clinical Investigation Dual-Degree Program.

Gillman J, Pillinger M, Plottel CS, Galeano C, Maddalo S, Hochman JS, Cronstein BN, Gold-von Simson G.

Clin Transl Sci. 2015 Dec;8(6):734-9. doi: 10.1111/cts.12328.


MY APPROACH to the management of cardiogenic shock.

Hochman JS, Reyentovich A.

Trends Cardiovasc Med. 2015 Aug;25(6):561-2. doi: 10.1016/j.tcm.2014.11.015. No abstract available.


Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes.

Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL; BARI 2D Study Group..

N Engl J Med. 2015 Aug 13;373(7):610-20. doi: 10.1056/NEJMoa1415921.


The reply.

Bangalore S, Gupta N, Guo Y, Lala A, Balsam L, Roswell RO, Reyentovich A, Hochman JS.

Am J Med. 2015 Aug;128(8):e25. doi: 10.1016/j.amjmed.2015.04.005. No abstract available.


Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years.

Kragholm K, Halim SA, Yang Q, Schulte PJ, Hochman JS, Melloni C, Mahaffey KW, Moliterno DJ, Harrington RA, White HD, Armstrong PW, Ohman EM, Van de Werf F, Tricoci P, Alexander JH, Giugliano RP, Newby LK.

Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):357-67. doi: 10.1161/CIRCOUTCOMES.114.001615.


Improving outcomes in older women?

Dodson JA, Hochman JS.

JACC Cardiovasc Interv. 2015 May;8(6):797-9. doi: 10.1016/j.jcin.2015.02.006. No abstract available.


Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.

Reynolds HR, Picard MH, Hochman JS.

Circ Cardiovasc Imaging. 2015 May;8(5):discussion p 9. doi: 10.1161/CIRCIMAGING.113.000362. No abstract available.


Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.

White HD, Westerhout CM, Alexander KP, Roe MT, Winters KJ, Cyr DD, Fox KA, Prabhakaran D, Hochman JS, Armstrong PW, Ohman EM; TRILOGY ACS investigators..

Eur Heart J Acute Cardiovasc Care. 2016 Jun;5(3):231-42. doi: 10.1177/2048872615581502.

Items per page

Supplemental Content

Loading ...
Support Center